07Jul 2023
Not just snot: local inflammatory profiles in patients with aspirin‐exacerbated respiratory disease differ from patients with aspirin‐tolerant chronic rhinosinusitis

Not just snot: local inflammatory profiles in patients with aspirin‐exacerbated respiratory disease differ from patients with aspirin‐tolerant chronic rhinosinusitis

In a recent study, researchers have discovered that patients with aspirin-exacerbated respiratory disease (AERD) have higher levels of IL-5, CCL2, and CXCL8 in their sinus mucous compared to aspirin-tolerant patients with chronic rhinosinusitis (CRS). These mediators play a crucial role in triggering widespread inflammatory responses that contribute to AERD. The findings highlight that AERD is not solely a type 2 (T2) disease but rather a heterogeneous condition, which may explain its resistance to treatment. This study sheds light on the complex nature of AERD and calls for further research to improve its management.

  • #ent

Like

Save

Share